It clearly shows that an efficient vaccine against leishmaniasis should not only induce IFN-γ-, TNF- and IL-2-secreting memory T cells [41], but also needs to prevent the development of antigen-specific IL-10-secreting T cells. This evidence concerns the gene IL2 and leishmaniasis.